Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Imaging Tests
Paranasal Sinus Cancer Markets and Competition Outlook 2026-2030 - Precision Oncology, Minimally Invasive Surgeries, and Expanded Cancer Care Models Drive Revenue Growth Original
Dublin, March 30, 2026 (GLOBE NEWSWIRE) -- The "Paranasal Sinus Cancer Market Report 2026" has been added to ResearchAndMarkets.com's offering. The paranasal sinus cancer market has shown robust growth, with a size increase from $1.1 billion in 2025 to an expected $1.18 billion in 2026, at a CAGR of 6.7%. Historical growth factors include delayed diagnosis due to nonspecific symptoms, limited access to specialized oncology centers, and reliance on traditional treatment methods.
Mantle Cell Lymphoma Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Diagnosis, By Treatment, By End User, By Region & Competition, 2021-2031F
The Global Mantle Cell Lymphoma Market is projected to expand from USD 2.71 Billion in 2025 to USD 4.28 Billion by 2031, registering a CAGR of 7.91%. This rare and aggressive B-cell malignancy, marked by cyclin D1 overexpression, is seeing increased demand for therapeutics due to the rising prevalence of hematologic cancers in aging populations and the regulatory success of targeted oral drugs and immunotherapies.
Hepatitis C Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Treatment, By Diagnosis, By Route of Administration, By Distribution Channel, By Region & Competition, 2021-2031F
The Global Hepatitis C Market is projected to expand from USD 9.32 Billion in 2025 to USD 13.15 Billion by 2031, reflecting a compound annual growth rate of 5.91%. This sector encompasses the manufacturing and distribution of diagnostic tools and therapeutic agents, specifically Direct Acting Antivirals utilized to manage and eradicate hepatitis C infections.
Wilms Tumor Global Market Report 2025
Wilms tumor, also known as nephroblastoma, is a form of kidney cancer that primarily affects children, most commonly under the age of 5. The tumor originates in the kidneys, which are responsible for filtering waste from the blood and producing urine. Wilms tumor is marked by the abnormal growth of kidney cells and can present with symptoms such as an abdominal mass, pain, fever, hematuria (blood in the urine), and elevated blood pressure.
Uterine Sarcoma Global Market Report 2025
Uterine sarcoma is a rare and aggressive cancer that develops in the smooth muscle or connective tissue of the uterus, unlike the more common endometrial cancer, which originates in the uterine lining. This cancer is known for its rapid growth and ability to spread to other parts of the body, making early diagnosis and intervention essential for improving treatment outcomes. Uterine sarcomas are typically diagnosed using imaging tests, biopsies, and histological examination.
In-Depth Analysis Of The Global Febrile Neutropenia Market: Key Drivers, Trends, Growth Opportunities, And Forecast 2025-2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today! How Large Is The Febrile Neutropenia Market Today, And What Is Its Growth Projection? The febrile neutropenia market has expanded significantly in recent years. It will rise from $10.60 billion in 2024 to $11.31 billion in 2025 at a CAGR of 6.7%.
Key Trend Revolutionizing the Paranasal Sinus Cancer Market in 2025: Impact Of Rising Tobacco Use On The Market Growth In New Report
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today! What Is The Current Valuation And CAGR Of The Paranasal Sinus Cancer Market? The paranasal sinus cancer market has grown strongly in recent years. It is projected to rise from $1.03 billion in 2024 to $1.11 billion in 2025, with a CAGR of 7.1%.
Major Trend In The Glomerulonephritis Global Market 2025-2034: Breakthrough Non-Immunosuppressive Treatment For IgA Nephropathy
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today! How Has The Glomerulonephritis Market Grown, And Where Is It Headed Next? The glomerulonephritis market has grown steadily in recent years. It is expected to increase from $11.06 billion in 2024 to $11.64 billion in 2025, with a CAGR of 5.3%.
Key Trend Revolutionizing the Combined Pituitary Hormone Deficiencies Market in 2025: Technological Advancements In Combined Pituitary Hormone Deficiencies Market
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today! What Is The Current Valuation And CAGR Of The Combined Pituitary Hormone Deficiencies Market? The market size of combined pituitary hormone deficiencies has shown robust growth lately. It is anticipated to augment from $1.95 billion in 2024 to $2.07 billion in 2025, with a compound annual growth rate (CAGR) of 6.5%.
Comprehensive Insights of the Global Viral Hepatitis Market Advancements Highlighted by Key Drivers, Trends, Growth Opportunities, and Forecast for 2025-2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today! What Is The Present Size And Future Growth Outlook Of The Viral Hepatitis Market? In the past few years, the viral hepatitis market has been expanding consistently. Its size is projected to increase from $16.21 billion in 2024 to $16.93 billion in 2025, with a compound annual growth rate (CAGR) of 4.4%.
In-Depth Analysis Of The Global Pheochromocytoma Market Advancements Highlighted by : Key Drivers, Trends, Growth Opportunities, And Forecast 2025-2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today! How Large Is The Pheochromocytoma Market Today, And What Is Its Growth Projection? In recent times, the pheochromocytoma market has seen a steady expansion. Its growth is projected to increase from $3.03 billion in 2024 to $3.17 billion in 2025, representing a compound annual growth rate (CAGR) of 4.7%.
Global Hepatitis Diagnostic Tests Market Forecast: Key Growth Drivers, Trends, and Opportunities from 2025 to 2034 In New Report
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today! How Fast Is The Hepatitis Diagnostic Tests Market Expanding, And What Is Its Market Value? In recent times, there has been a significant rise in the market size for hepatitis diagnostic tests. The forecast for its growth indicates an increase from $4.64 billion in 2024 to $4.95 billion in 2025, showing a compound annual growth rate (CAGR) of 6.5%.
Global Uterine Sarcoma Market To Reach $3.59 Billion By 2029 With A Growth Rate Of 6.4% As Revealed In New Report
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today! What Are The Latest Market Size Figures And Growth Trends For The Uterine Sarcoma Market? The market for uterine sarcoma has experienced robust growth in the past few years. The market is projected to expand from $2.63 billion in 2024 to $2.81 billion in 2025, with a compound annual growth rate (CAGR) of 6.64%.
Gastric Cancer Market Outlook 2025-2034: Growth Drivers, Share, And Trends
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today! What Is The Current Valuation And CAGR Of The Gastric Cancer Market? The size of the gastric cancer market has undergone rapid expansion in the last few years. It is projected to increase from $3.17 billion in 2024 to $3.65 billion in 2025, reflecting a compound annual growth rate (CAGR) of 15.4%.
Comprehensive Insights of the Global Campath/MabCampath Market Advancements Highlighted by Key Drivers, Trends, Growth Opportunities, and Forecast for 2025-2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today! How Large Is The Campath/MabCampath Market Today, And What Is Its Growth Projection? In recent years, the campath/mabcampath market has seen a rate of $XX (CAGR). Projected growth details indicate the market size rising from $XX million in 2024 to $XX million in 2025, showing a Compound Annual Growth Rate (CAGR) of $XX%.
Acute Spinal Cord Injury Market Set For 5.5% Growth, Reaching $8.77 Billion By 2029
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today! What Is The Market Size And Growth Rate Of The Acute Spinal Cord Injury Market? In the past few years, there has been significant growth in the market size of acute spinal cord injury. It is projected to increase from $6.7 billion in 2024 to $7.08 billion in 2025, indicating a compound annual growth rate (CAGR) of 5.6%.
Multiple Myeloma Market Shows Promising Growth with an Expected Reach of $38.39 Billion By 2029 at a CAGR of 8.1% As Discussed In New Market Research Report
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today! The Business Research Company (TBRC) unveils its latest report on Multiple Myeloma Market featuring key insights into its hardcore growth potential. The report shines a spotlight on various factors such as market size, CAGR, drivers and trends moulding the market dynamics in recent years and shaping its future.
Slip Disc Global Market Report 2024
A slip disc is a condition where an intervertebral disc in the spine bulges or herniates, pressing on nearby nerves. This happens when the disc's gel-like core displaces through a weakened outer layer, potentially causing symptoms such as back pain, leg pain, numbness, or weakness in the affected areas. The main types of slip discs are thoracic herniated discs, lumbar herniated discs, and cervical herniated discs.
Combined Pituitary Hormone Deficiencies Global Market Report 2024
Combined pituitary hormone deficiencies are a rare condition marked by the inadequate production of two or more hormones by the pituitary gland. This disorder usually arises from developmental or functional abnormalities, leading to symptoms that can include growth and developmental delays, infertility, and metabolic issues. Treatment typically involves lifelong hormone replacement therapy to manage symptoms and enhance quality of life.
Pheochromocytoma Industry to Witness Massive Growth (2024-2031)
The Pheochromocytoma Market size is growing at a high CAGR during the forecast period (2024-2031). This market research report examines key players such as: Septodont, Abbott Laboratories, Jubilant Cadista Pharmaceuticals Inc., Pfizer Inc., ANI Pharmaceuticals, Inc. DataM Intelligence has published a new research report on “Pheochromocytoma Market Size 2024”.
Hepatitis C Market By Size, Share and Forecast 2029F
Buy Now The report will be delivered in PDF format but without printing rights. It is recommended for individual clients for their personal use only. Single User Licence $4900 The report will be delivered in printable PDF format along with the report’s data excel sheet for internal analysis.
Prostate Cancer Diagnostics Market Insights and Growth Opportunities in 2024
Global Prostate Cancer Diagnostics Market reached US$ 5.1 billion in 2022 and is expected to reach US$ 11.6 billion by 2031 growing with a CAGR of 11.1% during the forecast period 2024-2031. The report named, "Global Prostate Cancer Diagnostics Market Research Report 2024" has been added to the archive of market research studies by DataM Intelligence.
Acute Spinal Cord Injury Market Overview, Competitive Analysis, Key Trends And Outlook By 2033
Acute Spinal Cord Injury Market Analysis The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033 The Business Research Company's Acute Spinal Cord Injury Global Market Report 2024 identifies increasing numbers of road accidents as the major driver for the acute spinal cord injury market's growth in the forecast period.
Hepatitis C Market Analysis, Trends, Growth, Research And Forecast 2032
Hepatitis C Market The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032 The Business Research Company's Hepatitis C Global Market Report 2023 identifies an increase in viral infections as the major driver for the hepatitis C market's growth in the forecast period. Viral infections refer to infections caused by a virus in the body.
Military Truck Market Analysis, Trends, Growth, Research And Forecast 2032
Hepatitis C Market The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032 The Business Research Company's Hepatitis C Global Market Report 2023 identifies an increase in viral infections as the major driver for the hepatitis C market's growth in the forecast period. Viral infections refer to infections caused by a virus in the body.
Multiple Myeloma Market Growth Rate, Trends, Key Drivers, Top Players And Outlook By 2032
Multiple Myeloma Market Analysis The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032 The Business Research Company's Multiple Myeloma Global Market Report 2023 identifies increasing prevalence of multiple myeloma as the major driver for the multiple myeloma market's growth in the forecast period. Multiple myeloma is a cancer that appears in a type of white blood cell called a plasma cell.
Insights into the Hepatitis Diagnosis Market | Key Players DiaSorin, Roche, Bio-Rad, bioMérieux
Hepatitis Diagnosis Market1 PORTLAND, OR, UNITED STATES, May 20, 2023 /EINPresswire.com/ -- Hepatitis Diagnosis Market- Global Outlook and Forecast 2023-2030 is latest research study released by Allied Market Research evaluating the market risk side analysis, highlighting opportunities and leveraged with strategic and tactical decision-making support (2023-2030). The market Study is segmented by key a region that is accelerating the marketization.
The Global Blood Cancer Diagnostics Market is Expected to Original
New York, USA, March 09, 2023 (GLOBE NEWSWIRE) -- The Global Blood Cancer Diagnostics Market is Expected to Showcase a Significant Growth at a CAGR of ~6% by 2027 | DelveInsight The blood cancer diagnostics market is expected to grow positively as a result of factors such as the increasing prevalence of blood cancer globally, increasing geriatric population, rising number of risk factors associated with blood cancer, and growing focus on improving the safety and usability of blood cancer...
Respiratory Disease Testing Market Shows Incredible Revenue Growth by 2032
PRESS RELEASE Published February 15, 2023 The Respiratory Disease Testing Market was valued at USD 11 Billion in 2020 and is anticipated to grow with a CAGR of 9.0% during the forecast period. The Respiratory Disease Testing Market research study provides critical market data, such as growth-influencing factors, roadblocks, and opportunities and strategies for overcoming them.
Global Blood Cancer Diagnostics Market to Grow at a Significant CAGR of 6.34% by 2027, Estimates DelveInsight | Key Companies - BD, Abbott, Agilent Technologies, Adaptive Biotechnologies, Roche, Invivoscribe, NeoGenomics, Inivata, Lucence, BioFluidica, Sk
February 9th, 2023 Releases As per DelveInsight’s assessment, the global blood cancer diagnostics market is estimated to grow at a CAGR of 6.34% during the forecast period from 2022 to 2027. The market is anticipated to grow owing to the growing prevalence of blood cancer worldwide, the increasing geriatric population, and the rising number of risk factors associated with blood cancer, along with the new products’ approval and launches.
Respiratory Disease Testing Market is Projected To Grow At a CAGR of 9% During The Forecast Period | Becton Dickinson & Company, Koninklijke Philips N.V., ResMed, Fischer & Paykel - Digital Journal
Growing sedentary lifestyle preferences and a growing population base in both developed and developing nations may support market expansion. The demand will also increase when more imaging modalities are implemented in diverse geographic places to detect COVID-19. The market is anticipated to develop as a result of the use of imaging technologies like computed tomography (CT) in the diagnosis of COPD.
Paraphilia Disorder Treatment Market Potential Growth, Share, Demand and Analysis Of Key Players- Research Forecast To 2029
The high quality Paraphilia Disorder Treatment market report has an extensive study about different market segments and regions, emerging trends along with major drivers, challenges and opportunities in the market. All the data, statistics, and information collected in the report has been studied and analysed with the demonstrated tools and techniques such as SWOT analysis and Porter’s Five Forces analysis.
Paranasal Sinus Cancer Market Value Is Estimated to Reach USD 2.8 Bn by 2028, With 4.00% CAGR – Credence Research - Digital Journal
Some of the major players in the paranasal sinus cancer market are AbbVie, Inc., Pfizer Inc., Eli Lilly and Company, Bristol-Myers Squibb Company, Hoffmann-La Roche Ltd., Becton, Dickinson and Company, Novartis AG, Ipsen Biopharmaceuticals Inc., Thermo Fisher Scientific, Abbott, G E Healthcare, Agilent Technologies Inc., AstraZeneca, Boehringer Ingelheim International GmbH and Bayer AG. The latest market report published by Credence Research, Inc.
Paraphilia Disorder Treatment Market Covid-19 Impact Analysis, Opportunities, Threats, Drivers, Restraints, Trends, Applications, And Growth Forecast To 2029 - Digital Journal
The consistent Paraphilia Disorder Treatment market report unearths the general market conditions, trends, preferences, key players, opportunities, geographical analysis and many other parameters that help drive business into the right direction. This market research report explains everything in detail that serves the business purpose and gives a competitive advantage.
Biogen and Lilly Advance Antibody Drugs to Treat Alzheimer’s Disease
The earlier Alzheimer’s disease is treated, the better. Maybe even before symptoms arise. That’s the idea behind experimental drugs designed to remove plaques from the brain and prevent cognitive changes. Today in Washington, both Eli Lilly and Biogen presented new data suggesting that antibodies designed to break up or clear the beta-amyloid plaques can slow the advancement of Alzheimer’s, particularly in patients with the mildest form of the disease.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Imaging
Contact Imaging, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack